Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | USP2 | O75604 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | BLM | P54132 | 1/20 | 0.44 |
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | MAOA | P21397 | 1/20 | 0.39 |
| ▸ | MAOB | P27338 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.36 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.36 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5441563 | 0.91 | HSD11B1 (0.44) | HSD11B1ALDH1A1USP2LMNACYP1A2 | |
| SCHEMBL5447800 | 0.91 | HSD11B1 (0.44) | HSD11B1ALDH1A1USP2LMNACYP1A2 | |
| SCHEMBL5441562 | 0.91 | HSD11B1 (0.44) | HSD11B1ALDH1A1USP2LMNACYP1A2 | |
| SCHEMBL5439925 | 0.86 | HSD11B1 (0.42) | HSD11B1ALDH1A1USP2LMNACYP1A2 | |
| SCHEMBL5439928 | 0.86 | HSD11B1 (0.42) | HSD11B1ALDH1A1USP2LMNACYP1A2 | |
| SCHEMBL5441874 | 0.86 | HSD11B1 (0.42) | HSD11B1ALDH1A1USP2LMNACYP1A2 | |
| SCHEMBL5443227 | 0.82 | HSD11B1 (0.40) | HSD11B1ALDH1A1USP2LMNACYP1A2 | |
| SCHEMBL5440008 | 0.82 | HSD11B1 (0.43) | HSD11B1ALDH1A1USP2LMNACYP1A2 | |
| SCHEMBL5438635 | 0.82 | HSD11B1 (0.43) | HSD11B1ALDH1A1USP2LMNACYP1A2 | |
| SCHEMBL5436174 | 0.82 | HSD11B1 (0.40) | HSD11B1ALDH1A1USP2LMNACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1032555-B1 | CYCLIC AMINO ACIDS AND DERIVATIVES THEREOF USEFUL AS PHARMACEUTICAL AGENTS | WARNER LAMBERT CO (US) | 2006-04-12 | — | — | EP | claimed |
| US-6921835-B2 | Cyclic amino acids and derivatives thereof useful as pharmaceutical agents | WARNER LAMBERT COMPANY (US) | 2005-07-26 | — | — | US | claimed |
| CN-1500773-A | Cyclic amino acids and derivatives thereof useful as pharmaceutical agents | ��ʲ | 2004-06-02 | — | — | CN | claimed |
| US-20030220397-A1 | Cyclic amino acids and derivatives thereof useful as pharmaceutical agents | BRYANS JUSTIN STEPHEN (GB) | 2003-11-27 | — | — | US | claimed |
| US-20030212133-A1 | Gabapentin analogues for sleep disorders | BRYANS JUSTIN STEPHEN (GB) | 2003-11-13 | — | — | US | claimed |
| CN-1436075-A | Gabapentin analogues for sleep disorders | WARNER LAMBERT CO (US) | 2003-08-13 | — | — | CN | claimed |
| EP-1296671-A2 | GABAPENTIN ANALOGUES FOR SLEEP DISORDERS | WARNER-LAMBERT COMPANY (US) | 2003-04-02 | — | — | EP | claimed |
| WO-2002000209-A2 | GABAPENTIN ANALOGUES FOR SLEEP DISORDERS | WARNER-LAMBERT COMPANY (US) | 2002-01-03 | — | — | WO | claimed |
| CN-1276784-A | Cyclic amino acids and their organisms as medicaments | WARNER LAMBERT CO (US) | 2000-12-13 | — | — | CN | claimed |
| CN-101283995-A | Different pharmaceutical uses alpha2delta ligands | WARNER LAMBERT CO (US) | 2008-10-15 | — | — | CN | disclosed |
| CN-100367946-C | Gabapentin analogs for the treatment of fibromyalgia and other disorders | WARNER LAMBERT CO (US) | 2008-02-13 | — | — | CN | disclosed |
| US-20070293570-A1 | PHARMACEUTICAL USES FOR ALPHA2DELTA LIGANDS | WARNER-LAMBERT COMPANY (US) | 2007-12-20 | — | — | US | disclosed |
| US-20070276039-A1 | PHARMACEUTICAL USES FOR ALPHA2DELTA LIGANDS | WARNER-LAMBERT COMPANY LLC (US) | 2007-11-29 | — | — | US | disclosed |
| US-20070213401-A1 | PHARMACEUTICAL USES FOR ALPHA2DELTA LIGANDS | WARNER-LAMBERT COMPANY LLC (US) | 2007-09-13 | — | — | US | disclosed |
| US-6635673-B1 | 1-Aminomethyl-3,4-dimethyl-cyclopentyl acetic acid; epilepsy; neurodegenerative, neuropathological and gastrointestinal disorders; depression, anxiety, panic, pain | WARNER-LAMBERT COMPANY | 2003-10-21 | — | — | US | disclosed |
| WO-2003070237-A1 | COMBINATIONS OF AN ALPHA-2-DELTA LIGAND WITH A SELECTIVE INHIBITOR OF CYCLOOXYGENASE-2 | WARNER-LAMBERT COMPANY LLC (US) | 2003-08-28 | — | — | WO | disclosed |
| CN-1436075-A | Gabapentin analogues for sleep disorders | WARNER LAMBERT CO (US) | 2003-08-13 | — | — | CN | disclosed |
| CN-1276784-A | Cyclic amino acids and their organisms as medicaments | WARNER LAMBERT CO (US) | 2000-12-13 | — | — | CN | disclosed |
| EP-1032555-A1 | CYCLIC AMINO ACIDS AND DERIVATIVES THEREOF USEFUL AS PHARMACEUTICAL AGENTS | WARNER-LAMBERT COMPANY (US) | 2000-09-06 | — | — | EP | disclosed |
| WO-1999021824-A1 | CYCLIC AMINO ACIDS AND DERIVATIVES THEREOF USEFUL AS PHARMACEUTICAL AGENTS | WARNER-LAMBERT COMPANY (US) | 1999-05-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070213401-A1 | PHARMACEUTICAL USES FOR ALPHA2DELTA LIGANDS | ADRA2A, ADRA1D, OPRD1 | HSD11B1 416/4885ALDH1A1 268/4885USP2 4327/4885 |
| US-20030220397-A1 | Cyclic amino acids and derivatives thereof useful as pharmaceutical agents | APC, VIP, NPSR1 | HSD11B1 3964/4885ALDH1A1 3481/4885USP2 4204/4885 |
| US-20070293570-A1 | PHARMACEUTICAL USES FOR ALPHA2DELTA LIGANDS | ADRA2A, ADRA1D, OPRD1 | HSD11B1 416/4885ALDH1A1 268/4885USP2 4327/4885 |
| US-20070276039-A1 | PHARMACEUTICAL USES FOR ALPHA2DELTA LIGANDS | ADRA2A, ADRA1D, OPRD1 | HSD11B1 416/4885ALDH1A1 268/4885USP2 4327/4885 |
| US-20030212133-A1 | Gabapentin analogues for sleep disorders | GABRA1, SLC6A1, GABRB1 | HSD11B1 432/4885ALDH1A1 757/4885USP2 4432/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.